This peptide is supplied as a lyophilized powder for reconstitution and is intended exclusively for in-vitro research purposes
Because we are a healthcare provider, our attention is on medical necessity, safe dosing, and patient care
Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells
Early-phase human trials are small, well-controlled studies centered on safety, reproductive hormones, and surrogate markers such as ovarian reserve tests and sperm parameters ahead of any efficacy trials
GHK-Cu will be voted on in a subsequent February 2027 meeting HHS has announced that GHK-Cu is expected to return to Category 1 (after being moved to Category 2 in September 2023), which would restore compounding access for injectable formulations. The dosing below draws from the per-component research and is reflected in the FDA review committee documents for each peptide, which aligns with PeptideFoxs previous research
This fast-absorbing formula supports skin that looks more refined, hydrated, and revitalized with continued use
